Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Herborium | OTC Markets | Healthcare | Biotechnology & Medical Research | $10.90L | 0x | $0 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Isodiol Intl | OTC Markets | Healthcare | Pharmaceuticals | $12.85K | 0x | $0.00010 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Zhuding | OTC Markets | Industrials | Professional & Commercial Services | $19.20L | -0x | $0 | -22.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
DeFi Tech | OTC Markets | Financial | Banking Services | $58.07Cr | 12.3x | 0.06 | $2.09 | 5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Acura Pharma | OTC Markets | Healthcare | Biotechnology & Medical Research | $3.32L | -0.1x | $0.005 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Ast Spacemobile | NASDAQ | Technology | Telecommunications Services | $774Cr | -21.4x | 0.52 | $28.01 | -6.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 20.6% Upside | Upgrade to Pro+ | |
Fastbase | OTC Markets | Technology | Software & IT Services | $97.60L | $0.09 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Itokk | OTC Markets | Financial | Investment Holding Companies | $3.03L | $0.0006 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Labor Smart Inc | OTC Markets | Industrials | Professional & Commercial Services | $4.69Cr | $0.003 | -9.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Candel Therapeutics | NASDAQ | Healthcare | Biotechnology & Medical Research | $22.65Cr | -4.2x | 0.08 | $7.03 | -3.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
LianBio ADR | OTC Markets | Healthcare | Biotechnology & Medical Research | $3.65Cr | -5.1x | -0.02 | $0.34 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Viking Therapeutics Inc | NASDAQ | Healthcare | Biotechnology & Medical Research | $698Cr | -67.5x | 19.5 | $62.94 | -6.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Dazed | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $6.21L | 1.5x | $0.0008 | -11.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
AKA Brands Holding | NYSE | Consumer Cyclicals | Specialty Retailers | $28.61Cr | -1.8x | -0.06 | $26.16 | -3.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -26.3% Downside | Upgrade to Pro+ | |
South Beach Spirits | OTC Markets | Real Estate | Real Estate Operations | $9.28L | -1.1x | $0 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
KYN Capital | OTC Markets | Technology | Software & IT Services | $62.20L | -0x | $0.0009 | -19% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
FTAI Aviation | NASDAQ | Financial | Banking Services | $1.30KCr | -235.6x | 1.3 | $126.77 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 4% Upside | Upgrade to Pro+ | |
Casi Pharma | NASDAQ | Healthcare | Pharmaceuticals | $10.09Cr | -3.3x | -0.12 | $6.89 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -12.9% Downside | Upgrade to Pro+ | |
Rezolute | NASDAQ | Healthcare | Biotechnology & Medical Research | $27.57Cr | -4.4x | 7.91 | $4.99 | -3.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Red Cat Holdings | NASDAQ | Industrials | Aerospace & Defense | $22.22Cr | -7.4x | -0.47 | $2.95 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Giant Motorsports | OTC Markets | Consumer Cyclicals | Specialty Retailers | $80.20L | -75x | $0.007 | -34.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
CervoMed | NASDAQ | Healthcare | Biotechnology & Medical Research | $13.31Cr | -19.7x | $16.14 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Identa | OTC Markets | Industrials | Machinery, Tools, Heavy Vehicles, Trains & Ships | $22.50L | 3.2x | $0.56 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Eliem Therapeutics | NASDAQ | Healthcare | Biotechnology & Medical Research | $55.26Cr | -2.7x | 0.26 | $7.96 | -3.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sky Harbour | NYSE | Industrials | Transport Infrastructure | $85.55Cr | -11x | 0.07 | $12.27 | -7.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 20.8% Upside | Upgrade to Pro+ | |
Aquestive Therapeutics | NASDAQ | Healthcare | Pharmaceuticals | $43.94Cr | -13.9x | -1.17 | $4.79 | -3.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Plastic2Oil Inc | OTC Markets | Basic Materials | Chemicals | $2.50L | -0.1x | $0.002 | -48.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Entera Bio | NASDAQ | Healthcare | Biotechnology & Medical Research | $7.59Cr | -8.1x | -0.28 | $2.12 | 4.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Praxis Precision | NASDAQ | Healthcare | Biotechnology & Medical Research | $102Cr | -5.9x | -0.11 | $57.72 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Neurogene | NASDAQ | Healthcare | Biotechnology & Medical Research | $52.03Cr | 147.8x | 2.26 | $40.27 | -5.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 20.4% Upside | Upgrade to Pro+ |